Psychemedics Corporation
PMDI
$2.30
$0.062.68%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.43M | 5.18M | 4.73M | 5.36M | 5.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.43M | 5.18M | 4.73M | 5.36M | 5.00M |
| Cost of Revenue | 3.04M | 3.14M | 3.18M | 3.24M | 2.94M |
| Gross Profit | 1.39M | 2.04M | 1.55M | 2.12M | 2.06M |
| SG&A Expenses | 1.04M | 2.46M | 2.26M | 2.48M | 2.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.26M | 5.77M | 5.63M | 5.92M | 5.87M |
| Operating Income | 168.00K | -595.00K | -899.00K | -567.00K | -868.00K |
| Income Before Tax | 160.00K | -606.00K | -898.00K | -572.00K | -876.00K |
| Income Tax Expenses | -29.00K | -71.00K | -71.00K | 116.00K | 69.00K |
| Earnings from Continuing Operations | 189.00K | -535.00K | -827.00K | -688.00K | -945.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 189.00K | -535.00K | -827.00K | -688.00K | -945.00K |
| EBIT | 168.00K | -595.00K | -899.00K | -567.00K | -868.00K |
| EBITDA | 267.00K | -302.00K | -595.00K | -246.00K | -743.00K |
| EPS Basic | 0.03 | -0.09 | -0.14 | -0.12 | -0.16 |
| Normalized Basic EPS | 0.02 | -0.06 | -0.10 | -0.06 | -0.09 |
| EPS Diluted | 0.03 | -0.09 | -0.14 | -0.12 | -0.16 |
| Normalized Diluted EPS | 0.02 | -0.06 | -0.10 | -0.06 | -0.09 |
| Average Basic Shares Outstanding | 5.99M | 5.89M | 5.82M | 5.81M | 5.81M |
| Average Diluted Shares Outstanding | 5.99M | 5.89M | 5.82M | 5.81M | 5.81M |
| Dividend Per Share | -- | -- | -- | -- | 0.00 |
| Payout Ratio | -- | -- | -- | -- | 0.00% |